文献类型：期刊文章

作　　者：张英涛[1] 王弘[1] 刘文芝[2] 佟巍[1] 杨雁芳[1] 艾铁民[1]

机构地区：[1]北京大学药学院,北京100083 [2]北京市怀柔区药用植物研究所

出　　处：《北京大学学报（医学版）》

基　　金：国家中医药管理局重大科技开发项目 ( 2 0 0 1 10 )~~

年　　份：2004

卷　　号：36

期　　号：1

起止页码：90-93

语　　种：中文

收录情况：AJ、BDHX、BDHX2000、CAS、CSCD、CSCD2011_2012、EMBASE、IC、JST、PUBMED、RCCSE、SCOPUS、ZGKJHX、核心刊

摘　　要：Echinacea is a most famous "immune herb" in western countries, and continues to be the best selling herb for many years. For the last five years, our research group has cooperated with Institute of Medicinal Plants in Huairou District of Beijing, carrying out studies on Echinacea purpurea, which involved botany, cultivation, pharmacognosy, phytochemistry, quality control, pharmacology and toxicology of the species. Two other species introduced from Canada, Echinacea angustifolia and Echinacea pallida, were also included in the taxonomic, cultivated and pharmacognostic studies. The results acquired have opened up the path to introduce Echinacea species into Traditional Chinese Medicine, thus established the possibility of developing more promising drugs from them.

关 键 词：松果菊属  药用植物 植物提取物 药理学 生药鉴别

分 类 号：R282.71[中药学类]